Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
6.50
+0.04 (0.70%)
At close: Aug 1, 2025, 4:00 PM
6.48
-0.01 (-0.23%)
After-hours: Aug 1, 2025, 4:10 PM EDT
Revance Therapeutics Market Cap
Immatics has a market cap or net worth of $787.65 million as of August 1, 2025. Its market cap has decreased by -37.77% in one year.
Market Cap
787.65M
Enterprise Value
219.80M
1-Year Change
-37.77%
Ranking
Category
Stock Price
$6.50
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $787.65M, an increase of 356.61%. That is a compound annual growth rate of 25.69%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 787.65M | -7.19% |
Dec 31, 2024 | 848.62M | -4.80% |
Dec 29, 2023 | 891.43M | 34.26% |
Dec 30, 2022 | 663.94M | -21.47% |
Dec 31, 2021 | 845.50M | 24.56% |
Dec 31, 2020 | 678.78M | 263.23% |
Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 684.37B |
Johnson & Johnson | 402.99B |
AbbVie | 344.84B |
AstraZeneca | 228.08B |
Novartis AG | 224.47B |
Abbott Laboratories | 221.54B |
UnitedHealth Group | 215.69B |
Novo Nordisk | 211.90B |